An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins

Atherosclerosis

Volumn 119, Issue 2, 1996, Pages 215-222

  JHaines, Christopher J ^a   Chung, Tony K H ^a   Masarei, John R L ^a   Tomlinson, Brian ^a   Lau, Joseph T F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Coronary heart disease; Lipoprotein(a); Lipoproteins; Menopause

Indexed keywords

APOLIPOPROTEIN B; ESTRADIOL; ESTROFEM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030045451     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05650-5     Document Type: Article

References (35)

1. Gambrell RD Jr. Cancer and the use of estrogens. Int J Fertil 1986;31:112-122.
2. Walsh BW, Schiff I, Rosner B. et al. Effects of post-menopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325;1196-1204.
3. Schaefer EJ, Foster DM, Zech LA. et al. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 1983;183 262-183 267.
4. Kushwaha RS, Foster DM, Murthy VN. et al. Metabolic regulation of apoproteins of high-density lipoproteins by estrogen and progesterone in the baboon (Papio sp.). Metabolism 1990;39:544-552.
5. Kushwaha RS, Foster DM, Barrett PHR, et al. Effect of estrogen and progesterone in metabolism of apoprotein B in baboons. Am J Physiol 1990;258:E172-E183.
6. Rijpkema AHM, van der Sanden AA, Ruijs AHC. Effects of post-menopausal oestrogen progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas 1990;12:254-285.
7. Rosengren A, Wilhelmsen L, Eriksson E, et al. Lipoprotein (a) and coronary heart disease: a prospective case control study in a general population sample of middle aged men. Br Med J 1990;301:1248-1251.
8. Jovicic A, Ivanisevic V, Ivanovic I. Lipoprotein(a) in patients with carotid atherosclerosis and ischaemic cerebrovascular disorders. Atherosclerosis 1993;98:59-65.
9. Brewer HB. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In: Scanu AM. (ed). Lipoprotein(a). San Diego, CA: Academic Press 1990;211-220.
10. Meilahn EN, Kuller LH, Matthews KA, et al. Lp(a) concentrations among pre- and postmenopausal women over time: The Healthy Women Study. Circulation 1991;84(Suppl II):546.
11. Heinrich J, Sandkamp M, Kokott R, et al. Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991;37:1950-1954.
12. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein-cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-505.
13. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
14. Hirvonen E, Lipasti A, Malkonen M, et al. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in postmenopausal women. Maturitas 1987;9:69-79.
15. Ottosson UB, Johansson BG, von Schoultz B. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone. Am J Obstet Gynecol 1985;151:746-750.
16. Prough SG, Aksel S, Wiebe RH, et al. Continuous estrogen progestin therapy in menopause. Am J Obstet Gynecol 1987;157:1449-1453.
17. Parish E, Rolton HA, Barnes JF, et al. Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. Br Med J 1991:303.
18. Crook D, Sidhu M, Seed M, et al. Lp(a) levels in women given danazol, an anabolic steroid. Atherosclerosis 1992;92:41-47.
19. Albers JJ, Taggart HCA, Applebaum-Bowden D, et al. Reduction of lecithin cholesterol acyltransferase apolipoprotein D, and the Lp(a) lipoprotein with the anabolic steroid stanozolol. Biochim Biophys Acta 1984;795:293-296.
20. Kim CJ, Jang HC, Cho DC, et al. Effects of hormone replacement therapy on lipoprotein (a) and lipids in postmenopausal women. Arteriosclerosis Thromb 1994;14:275-281.
21. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994;154:1106-1110.
22. Parish E, Barnes JF, Rolton HA, et al. Effects of tibolone on lipoprotein (a) and HDL subfractions. Maturitas 1995;20:215-219.
23. Rymer J, Crook D, Sidhu M. et al. Effects of tibolone on serum concentrations of lipoprotein (a) in postmenopausal women. Acta Endocrinol 1993;128:259-262.
24. Schriewer H, Assmann G, Sandkamp M. The relationship of lipoprotein (a) (Lp(a)) to risk factors of coronary heart disease: initial results of the prospective epidemiological study on company employees in Westfalia. J Clin Chem Clin Biochem 1984;22:591-596.
25. Soma MR, Osnago-Gadda I, Paoletti R, et al. The lowering of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993;153:1462-1468.
26. Cobbaert C, Kesteloot H. Serum lipoprotein (a) levels in racially different populations. Am J Epidemiol 1992;136:441-449.
27. Cho YT, Donnan SPD. Comparisons with risk factors for heart disease in other Hong Kong studies and in other countries. Health risks, fitness and quality of life in adults in Hong Kong. In: The Cooperative Cross-Disciplinary Research Project on Physical Activity and Quality of Life in Densely Populated Urban Areas. Phase Two Study Report (Part One). The Chinese University of Hong Kong, School of Education and Department of Community Medicine, 1988;71-73.
28. Weinstein L. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient. Obstet Gynecol 1987;69:929-932.
29. Sherwin BB, Gelfand MM. A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 1989;73:759-766.
30. Van der Mooren MJ, Demacker PNM, Thomas CMG, et al. Beneficial effects on serum lipoproteins by 17β-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study. Eur J Obstet Gynecol Reprod Biol 1992;47:153-160.
31. Azogui G, Ben-Shlomo I, Zohar S, et al. High density lipoprotein concentration is increased during the ovulatory phase of the menstrual cycle in healthy young women. Gynecol Endocrinol 1992;6:253-257.
32. Lyons Wall PW, Choudhury N, Gerbrandy EA, et al. Increase of high-density lipoprotein cholesterol at ovulation in healthy women. Atherosclerosis 1991;105:171-178.
33. De Leon RG, Austin KL, Richards L, et al. Lipid and hormonal profile of Panamanian women during the menstrual cycle. Int J Gynaecol Obstet 1992;39:219-226.
34. Lebech AM, Kjaer A, Lèbech PE. Metabolic changes during the normal menstrual cycle: a longitudinal study. Am J Obstet Gynecol 1990;163:414-416.
35. Owens D, Cox M, Caird J, et al. Altered regulation of cholesterol metabolism in type I diabetic women during the menstrual cycle. Diabet Med 1993;10:647-653.